Atlas FDA

Hintermann Series H3 Total Ankle Replacement System

FDA premarket approval P160036 · decided 2019-06-04

Approval details

PMA number
P160036
Trade name
Hintermann Series H3 Total Ankle Replacement System
Generic name
Prosthesis, ankle, uncemented, non-constrained
Applicant
Dt Medtech, LLC
Date received
2016-08-24
Decision date
2019-06-04
Days to decision
1014 days
Decision code
APPR
Product code
NTG
Advisory committee
Orthopedic
Expedited review
No
Location
Towson, MD
Statement
Approval for the Hintermann Series H3 Total Ankle Replacement System. The device is indicated for use as a non-cemented implant to replace a painful arthritic ankle joint due to primary osteoarthritis, post-traumatic osteoarthritis or arthritis secondary to inflammatory disease (e.g. rheumatoid arthritis, hemochromatosis, etc.). The device system is for prescription use.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Hintermann Series H2 Total Ankle System (K171004)Dt Medtech, LLC2017-11-07